|
WO2015171270A1
|
|
Method for the treatment of neurofibromatosis
|
|
WO2015171272A1
|
|
Method for treating muscular dystrophy
|
|
WO2015167791A2
|
|
Method for treating infectious diseases using emissive energy
|
|
US2015283237A1
|
|
Ctla-4 blockade with metronomic chemotherapy for the treatment of cancer
|
|
WO2013181016A2
|
|
Treatment for the rapid amelioration of clinical depression
|
|
WO2013177104A2
|
|
Treatment for tauopathies
|
|
WO2013177102A2
|
|
Treatment of cancer by manipulating the immune system
|
|
WO2013177098A1
|
|
A method for the treatment of neurologic conditions
|
|
WO2013142449A2
|
|
Treatment for chronic pain syndromes
|
|
US2014193514A1
|
|
Method for the Treatment of Cancer
|
|
WO2012151093A1
|
|
Treatment for tauopathies
|
|
US2011295175A1
|
|
Sequential Extracoporeal Treatment of Bodily Fluids
|
|
WO2010107789A1
|
|
Sequential extracorporeal treatment of bodily fluids
|
|
US2011251544A1
|
|
Utilization of stents for the treatment of blood borne carcinomas
|
|
US2011217278A1
|
|
Medication and treatment for disease
|
|
US2007036712A1
|
|
Method of hydrogen production utilizing sand for the maintenance of a high biomass bacteria in a hydrogen bioreactor
|
|
US2007037268A1
|
|
Hydrogen producing bioreactor with sand for the maintenance of a high biomass bacteria
|
|
US2007082387A1
|
|
Method of hydrogen production combining a bioreactor with a nuclear reactor and associated apparatus
|
|
US2006272955A1
|
|
Dual method of hydrogen production
|
